Compare NeoGenomics Inc. Common Stock (NEO) vs DENTSPLY SIRONA Inc (XRAY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
NeoGenomics Inc. Common Stock vs DENTSPLY SIRONA Inc — how do they compare? NeoGenomics Inc. Common Stock trades at $17.17 (market cap $2.17B), while DENTSPLY SIRONA Inc trades at $8.54 (market cap $1.68B). The key difference: NeoGenomics Inc. Common Stock is the larger of the two by market cap, and DENTSPLY SIRONA Inc pays a 5.04% dividend while NeoGenomics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold NeoGenomics Inc. Common Stock for 0 Days and DENTSPLY SIRONA Inc for 72 Days on average.
| NEO | XRAY | |
|---|---|---|
Market Cap | $2.17B | $1.68B |
Volume | 1,615,943 | 3,968,929 |
Sector | Health | Health |
52-Week High | $19.91 | $14.68 |
52-Week Low | $7.19 | $8.44 |
Typical Hold Time | 0 Days | 72 Days |
Enterprise Value | $2.47B | $3.76B |
Dividend Yield | — | 5.04% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
DENTSPLY SIRONA (XRAY) trades at $8.505, down 0.29% and near 52-week lows, with bearish technical signals and mixed fundamentals. The company reported Q2 2026 EPS of $0.52 beating estimates but faces declining revenue and negative margins. Recent news highlights institutional stake increases and ongoing restructuring efforts amid weak dental market conditions.
The stock presents a high-risk opportunity with analyst consensus at $12.50 (47% upside) but requires careful monitoring of margin recovery and sales stabilization. Key risks include persistent net losses, competitive pressures, and execution challenges in the turnaround plan.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About NeoGenomics Inc. Common Stock
NeoGenomics, Inc. is a US cancer diagnostics company that provides genomic and pathology testing services, offering an oncology-focused testing menu used by oncologists, pathologists, and hospital systems across the cancer care continuum.
Read more on NEO →About DENTSPLY SIRONA Inc
Dentsply Sirona Inc is a global manufacturer and distributor of dental supplies and equipment. The company's operating segments include Technologies & Equipment, which is responsible for the design, manufacture, sales, and distribution of products including dental implants, CAD/CAM systems, orthodontic clear aligner products, imaging systems, treatment centers, instruments, as well as certain healthcare device products, primarily catheters
Read more on XRAY →
